One of Eli Lilly's potential competitors in the weight loss market just reported unimpressive trial results. The company ...
Eli Lilly said it would invest $3 billion to expand a recently ... Zepbound and Mounjaro. Lilly’s rival, Novo ...
Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its popular ...
Prescription fills for weight loss drugs more than doubled in 2024 despite limited insurance coverage and high costs, ...